{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:46:07Z","timestamp":1794566767914,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660677"],"award-info":[{"award-number":["81660677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760655"],"award-info":[{"award-number":["81760655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.prostaglandins.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T22:18:41Z","timestamp":1554329921000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Regulation of nicotinic acetylcholine receptor \u03b13 subtype in adipose tissue dysfunction"],"prefix":"10.1016","volume":"142","author":[{"given":"Xiaoqing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3178-8163","authenticated-orcid":false,"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/bph.14181","article-title":"Adipokines and inflammation: is it a question of weight?","volume":"175","author":"Francisco","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0010","doi-asserted-by":"crossref","first-page":"T47","DOI":"10.1530\/JOE-13-0339","article-title":"Adipocytokines in obesity and metabolic disease","volume":"220","author":"Cao","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/jpet.103.065037","article-title":"The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes","volume":"310","author":"Liu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0035","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/bph.13609","article-title":"Role of the nicotinic acetylcholine receptor alpha3 subtype in vascular inflammation","volume":"173","author":"Yang","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbmt.2017.11.024","article-title":"Adipokines, inflammation, and adiposity in hematopoietic cell transplantation survivors","volume":"24","author":"Ketterl","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3945\/an.114.005934","article-title":"Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity","volume":"5","author":"Aguilar","year":"2014","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bluher","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jjcc.2017.02.006","article-title":"The role of adipokines in cardiovascular disease","volume":"70","author":"Shibata","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1373\/clinchem.2017.275172","article-title":"Addressing the perfect storm: biomarkers in obesity and pathophysiology of cardiometabolic risk","volume":"64","author":"Aleksandrova","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2017.10.100","article-title":"LDL-cholesterol and atherosclerotic cardiovascular disease: innocent bystander or essential ingredient","volume":"71","author":"Egom","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/mol.51.2.336","article-title":"Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors","volume":"51","author":"Harvey","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4161\/cbt.7.11.6837","article-title":"Concomitant activation of the JAK\/STAT3 and ERK1\/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells","volume":"7","author":"Li","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0085","article-title":"Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting a7 nAChR and M4 mAChR and inhibiting JAK2\/STAT3 pathway in rats","volume":"8","author":"Weiwei Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.04.001_bib0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318301606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318301606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:45:09Z","timestamp":1565145909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882318301606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":18,"alternative-id":["S1098882318301606"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.04.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of nicotinic acetylcholine receptor \u03b13 subtype in adipose tissue dysfunction","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}